⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28644224 | 0.96 | CYP2A6 (0.47) | — | |
| SCHEMBL29649306 | 0.96 | CYP2A6 (0.47) | — | |
| SCHEMBL27384288 | 0.96 | — | — | |
| SCHEMBL30505849 | 0.96 | CYP2A6 (0.47) | — | |
| SCHEMBL30253511 | 0.96 | CYP2A6 (0.47) | — | |
| Hydrochloric Acid SCHEMBL2434708 | 0.96 | CYP2A6 (0.47) | — | |
| Benzene SCHEMBL7937270 | 0.96 | CYP2A6 (0.47) | — | |
| Fluoride SCHEMBL30505845 | 0.93 | CYP2A6 (0.44) | — | |
| Hydrochloric Acid SCHEMBL27365162 | 0.93 | CYP2A6 (0.44) | — | |
| SCHEMBL28013397 | 0.90 | CYP2A6 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16639 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080076-A | Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026106815-A1 | Z-INDUCING CHIMERA COMPOSITION | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4739647-A1 | PROCESS FOR PRODUCING METHANOL | C1 Green Chemicals AG (DE) | 2026-05-13 | — | — | EP | claimed |
| US-20260130106-A1 | PHOTOELECTRIC DEVICE AND PREPARATION METHOD THEREFOR | TCL TECHNOLOGY GROUP CORPORATION (CN) | 2026-05-07 | — | — | US | claimed |
| EP-4737001-A1 | POROUS CARBON CARRIER-SUPPORTED CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF | China Petroleum & Chemical Corporation (CN) | 2026-05-06 | — | — | EP | claimed |
| US-12616690-B2 | Specific AKT3 activator and uses thereof | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2026-05-05 | — | — | US | claimed |
| US-12616761-B2 | CXCR4-targeting compounds | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2026-05-05 | — | — | US | claimed |
| US-20260115176-A1 | ALLOSTERIC MODULATORS OF CANNABINOID RECEPTORS AND METHODS OF TREATING NEUROPATHIC PAIN | UNIV LELAND STANFORD JUNIOR (US) | 2026-04-30 | — | — | US | claimed |
| EP-3768675-B1 | NOVEL TRIAZOLONE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | YUHAN CORP (KR) | 2026-04-01 | — | — | EP | claimed |
| EP-4055088-B1 | COMPOSITION AND METHOD FOR MANUFACTURING RESINS | CAMBIUM BIOMATERIALS INC (US) | 2026-03-25 | — | — | EP | claimed |
| CN-101875627-A | 1-carbalkoxy-2H-isoindazole derivative, preparation method and intermediate thereof | KAIHUI TECHNOLOGY DEV SHANGHAI CO LTD | 2010-11-03 | — | — | CN | claimed |
| US-20040198741-A1 | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | WYETH | 2004-10-07 | — | — | US | claimed |
| EP-0871615-B1 | SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS | MERCK & CO INC (US) | 2004-07-14 | — | — | EP | claimed |
| US-20030195213-A1 | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | BAILEY THOMAS R (US) | 2003-10-16 | — | — | US | claimed |
| EP-1128832-A4 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING VIRAL INFECTIONS AND ASSOCIATED DISEASES | VIROPHARMA INC (US) | 2003-03-05 | — | — | EP | claimed |
| EP-1128832-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING VIRAL INFECTIONS AND ASSOCIATED DISEASES | Viropharma Incorporated (US) | 2001-09-05 | — | — | EP | claimed |
| US-6194581-B1 | FOR TREATMENT OF DYSFUNCTION OF THE CENTRAL OR AUTONOMIC NERVOUS SYSTEMS INCLUDING DEMENTIA, COGNITIVE DISORDERS, NEURODEGENERATIVE DISORDERS, EXTRAPYRAMIDAL DISORDERS, CONVULSIVE DISORDERS, CARDIOVASCULAR DISORDERS, PAIN | MERCK & CO., INC. | 2001-02-27 | — | — | US | claimed |
| WO-2000010573-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING VIRAL INFECTIONS AND ASSOCIATED DISEASES | VIROPHARMA INCORPORATED (US) | 2000-03-02 | — | — | WO | claimed |
| EP-0871615-A1 | SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS | SIBIA NEUROSCIENCES, INC. (US) | 1998-10-21 | — | — | EP | claimed |
| WO-1996031475-A2 | SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS | SIBIA NEUROSCIENCES, INC. (US) | 1996-10-10 | — | — | WO | claimed |